Charles has 20 years experience in bioinformatics research and entrepreneurship. Prior to joining us at Clear Labs, Charles co-founded Five3 Genomics, where he developed clinical whole-genome and whole-transcriptome LDTs for cancer treatment selection as Chief Scientific Officer. His research efforts have resulted in numerous patents and publications in cancer research and systems biology.
March, 2022 - present